What is the standard conventional fractionation schedule for external-beam radiation therapy in a male patient over 60 years old with localized prostate cancer and no prior pelvic radiation?

Conventional Fractionation for Prostate Cancer

For localized prostate cancer, the standard conventional fractionation schedule is 76-78 Gy delivered in 1.8-2.0 Gy fractions over approximately 8 weeks using IMRT/VMAT with IGRT. 1

Evidence-Based Fractionation Schedule

The EAU-EANM-ESTRO-ESUR guidelines establish conventional fractionation as 76-78 Gy total dose, which translates to:

• 38-39 fractions of 2.0 Gy each 1
• Treatment duration: 7.5-8 weeks 2
• Delivery technique: IMRT/VMAT with IGRT (intensity-modulated radiation therapy/volumetric modulated arc therapy with image-guided radiation therapy) 1

Risk-Stratified Application

Intermediate-Risk Disease

• 76-78 Gy conventional fractionation PLUS short-term ADT (4-6 months) is the guideline-recommended approach 1
• Focal boosting to MRI-defined dominant intraprostatic tumors can be offered when using conventional fractionation (1.8-2.0 Gy per fraction), ensuring organ-at-risk constraints are maintained 1

High-Risk and Locally Advanced Disease

• 76-78 Gy conventional fractionation PLUS long-term ADT (2-3 years) is strongly recommended 1
• Focal boosting to dominant lesions remains an option with the same dose-per-fraction constraints 1

Comparison to Hypofractionation

While conventional fractionation remains standard, the evidence demonstrates that moderate hypofractionation is non-inferior:

• 60 Gy in 20 fractions over 4 weeks showed equivalent 5-year biochemical-clinical failure-free survival (85% in both arms) with no increase in grade ≥3 late toxicity 2
• The radiobiological basis for hypofractionation stems from prostate cancer's exceptionally low α/β ratio of approximately 1.5 Gy, which is lower than the α/β of 3 Gy for late rectal complications 3

Critical Technical Considerations

Portal imaging verification should be performed on initial fractions and repeated at least weekly to ensure accurate targeting 4

Planning target volume margins of 8-10 mm from the clinical target volume (which includes prostate and base of seminal vesicles) are standard 4

Common pitfall: Avoid exceeding organ-at-risk dose constraints when implementing focal boost strategies, as this can significantly increase toxicity risk 1

Treatment Duration Flexibility

Radical prostatectomy (the surgical alternative) can be safely delayed for at least 3 months without compromising outcomes, suggesting some flexibility in treatment timing for radiation therapy as well 1